BG61101B1 - Антиалергичен състав с очно и назално приложение - Google Patents

Антиалергичен състав с очно и назално приложение Download PDF

Info

Publication number
BG61101B1
BG61101B1 BG98327A BG9832793A BG61101B1 BG 61101 B1 BG61101 B1 BG 61101B1 BG 98327 A BG98327 A BG 98327A BG 9832793 A BG9832793 A BG 9832793A BG 61101 B1 BG61101 B1 BG 61101B1
Authority
BG
Bulgaria
Prior art keywords
solution
cyclodextrin
cetirizine
composition
composition according
Prior art date
Application number
BG98327A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG98327A (bg
Inventor
Yoshifumi Ikejiri
Takahiro Ogawa
Fuminori Tokumochi
Shogo Sameshima
Motoko Kimura
Original Assignee
Senju Pharmaceutical Co.,Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co.,Ltd. filed Critical Senju Pharmaceutical Co.,Ltd.
Publication of BG98327A publication Critical patent/BG98327A/bg
Publication of BG61101B1 publication Critical patent/BG61101B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG98327A 1992-12-25 1993-12-23 Антиалергичен състав с очно и назално приложение BG61101B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34603192 1992-12-25

Publications (2)

Publication Number Publication Date
BG98327A BG98327A (bg) 1994-08-30
BG61101B1 true BG61101B1 (bg) 1996-11-29

Family

ID=18380671

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98327A BG61101B1 (bg) 1992-12-25 1993-12-23 Антиалергичен състав с очно и назално приложение

Country Status (23)

Country Link
US (1) US5419898A (de)
EP (1) EP0605203B1 (de)
JP (1) JP3683595B2 (de)
KR (1) KR100276743B1 (de)
CN (1) CN1050514C (de)
AT (1) ATE164068T1 (de)
AU (1) AU666413B2 (de)
BG (1) BG61101B1 (de)
CA (1) CA2112014C (de)
CZ (1) CZ283029B6 (de)
DE (1) DE69317537T2 (de)
DK (1) DK0605203T3 (de)
ES (1) ES2115733T3 (de)
FI (1) FI111805B (de)
HU (2) HU218672B (de)
LT (1) LT3344B (de)
LV (1) LV10688B (de)
NO (2) NO934630D0 (de)
NZ (1) NZ250519A (de)
PL (1) PL173347B1 (de)
RU (1) RU2130774C1 (de)
SK (1) SK279503B6 (de)
TW (1) TW401300B (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
EP0780127A1 (de) * 1995-12-19 1997-06-25 The Procter & Gamble Company Nasenspray enthaltend einen Steroid und einen Antihistamin
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5874450A (en) * 1996-09-27 1999-02-23 Nastech Pharmaceutical Company, Inc. Intranasal formulations for promoting sleep and method of using the same
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
EP0919550A1 (de) 1997-11-26 1999-06-02 Ucb, S.A. Pseudopolymorphische Formen der 2-2-4-Bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxyessigsäure Dihydrochloride
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
JP2002523475A (ja) 1998-09-02 2002-07-30 アラーガン・セイルズ・インコーポレイテッド 防腐したシクロデキストリン含有組成物
BR9804993A (pt) * 1998-11-10 2000-06-06 Panacea Biotec Ltd Composição antialérgica e antiinflamatória
JP2001125052A (ja) * 1999-10-25 2001-05-11 Lion Corp コンタクトレンズ装着液
US6258814B1 (en) * 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
EP1467715B1 (de) * 2002-01-15 2010-11-03 Ucb Farchim S.A. Formulierungen zur oralen verabreichung von wirkstoffen
AR038299A1 (es) * 2002-01-18 2005-01-12 Novartis Ag Metodos para conservar soluciones oftalmicas y soluciones oftalmicas conservadas.
JP4543274B2 (ja) * 2002-10-01 2010-09-15 大正製薬株式会社 点鼻剤組成物
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20050255154A1 (en) * 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
ES2624585T3 (es) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
JP2006008568A (ja) * 2004-06-24 2006-01-12 Cyclochem:Kk ＩｇＥ抗体抑制剤および食品
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
WO2006011051A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form
EP2336117A1 (de) 2005-05-26 2011-06-22 Neuron Systems, Inc Heterozyklische Verbindungen zur Behandlung retinaler Erkrankungen
WO2006137433A1 (ja) * 2005-06-21 2006-12-28 Wakamoto Pharmaceutical Co., Ltd. レボカバスチンを可溶化させた水性薬剤
CA2629904C (en) * 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
CA2645311C (en) * 2006-03-13 2014-11-18 R-Tech Ueno, Ltd. Aqueous composition comprising 15-keto-prostaglandin for ophthalmic use
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
CN101284026B (zh) * 2007-04-12 2010-11-10 鲁南制药集团股份有限公司 一种用于治疗皮肤过敏性疾病的药物组合物
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
US9358242B2 (en) * 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
CA2755679C (en) * 2009-03-17 2017-09-12 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8569273B2 (en) * 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) * 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US20120142704A1 (en) * 2009-08-12 2012-06-07 Lun Better Pharmaceutical Co., Ltd Pharmaceutical solution of cetirizine hydrochloride
WO2011057192A2 (en) 2009-11-06 2011-05-12 Yale University Amphiphilic compositions and methods for preparing and using same
WO2011072141A1 (en) 2009-12-11 2011-06-16 Neuron Systems, Inc. Compositions and methods for the treatment of macular degeneration
BR112014012985B1 (pt) 2011-11-29 2020-05-12 Jurox Pty Ltd Composição farmacêutica injetável, seu método de produção e uso, bem como método de conservação de uma composição farmacêutica injetável e uso de pelo menos um co-solvente e pelo menos um conservante
CA2898631C (en) 2013-01-23 2023-06-13 Aldeyra Therapeutics, Inc. Toxic aldehyde related diseases and treatment
CN108135907A (zh) 2015-08-21 2018-06-08 奥尔德拉医疗公司 氘化化合物和其用途
MX2018010292A (es) * 2016-02-28 2018-09-27 Aldeyra Therapeutics Inc Tratamiento de condiciones oculares alergicas con ciclodextrinas.
US11129823B2 (en) 2016-05-09 2021-09-28 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
WO2018147409A1 (ja) * 2017-02-13 2018-08-16 日東メディック株式会社 水性点眼点鼻用組成物
US10414732B2 (en) 2017-03-16 2019-09-17 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
MX2020003425A (es) 2017-10-10 2020-07-29 Aldeyra Therapeutics Inc Tratamiento de trastornos inflamatorios.
CA3088740A1 (en) * 2018-01-18 2019-07-25 Faes Farma, S.A. Ophthalmic compositions comprising bilastine, a beta-cyclodextrin and at least one gelling agent
EP3833660A4 (de) 2018-08-06 2022-05-11 Aldeyra Therapeutics, Inc. Polymorphe verbindungen und verwendungen davon
JP7505786B2 (ja) 2018-09-25 2024-06-25 アルデイラ セラピューティクス， インコーポレイテッド ドライアイ疾患を処置するための製剤
WO2020198064A1 (en) 2019-03-26 2020-10-01 Aldeyra Therapeutics, Inc. Ophthalmic formulations and uses thereof
EP3725298A1 (de) * 2019-04-16 2020-10-21 Faes Farma, S.A. Stabile und konservierte pharmazeutische zusammensetzungen von bilastin
US12098132B2 (en) 2019-05-02 2024-09-24 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
CA3137301A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
WO2021231792A1 (en) 2020-05-13 2021-11-18 Aldeyra Therapeutics, Inc. Pharmaceutical formulations and uses thereof
CN120437087A (zh) 2024-02-01 2025-08-08 科赴品牌有限责任公司 一种口腔溶解膜制剂、其用途及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
AU636685B2 (en) * 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
DE9015551U1 (de) * 1990-11-14 1992-03-12 Röhm GmbH, 6100 Darmstadt Orale Arzneiform und Überzugsmittel, enthaltend ein im Colon abbaubares Polysaccarid
JPH06311353A (ja) 1993-04-19 1994-11-04 Brother Ind Ltd カラー画像形成装置
JP2619828B2 (ja) 1996-06-17 1997-06-11 九州日立マクセル株式会社 電動式爪みがき機

Also Published As

Publication number Publication date
NZ250519A (en) 1995-03-28
FI111805B (fi) 2003-09-30
HU9303746D0 (en) 1994-04-28
HU218672B (hu) 2000-10-28
HUT69385A (en) 1995-09-28
NO934630D0 (no) 1993-12-15
LTIP1669A (en) 1994-10-25
NO934630L (no) 1994-06-27
KR100276743B1 (ko) 2001-01-15
CZ283693A3 (en) 1994-07-13
SK279503B6 (sk) 1998-12-02
JPH06239748A (ja) 1994-08-30
EP0605203A3 (de) 1994-11-02
EP0605203B1 (de) 1998-03-18
CN1050514C (zh) 2000-03-22
LV10688A (lv) 1995-06-20
JP3683595B2 (ja) 2005-08-17
RU2130774C1 (ru) 1999-05-27
ATE164068T1 (de) 1998-04-15
AU666413B2 (en) 1996-02-08
PL173347B1 (pl) 1998-02-27
AU5259793A (en) 1994-07-07
US5419898A (en) 1995-05-30
DE69317537D1 (de) 1998-04-23
FI935851A0 (fi) 1993-12-23
ES2115733T3 (es) 1998-07-01
PL301588A1 (en) 1994-06-27
DK0605203T3 (da) 1998-12-07
CA2112014A1 (en) 1994-06-26
CN1094614A (zh) 1994-11-09
CZ283029B6 (cs) 1997-12-17
LT3344B (en) 1995-07-25
HU211972A9 (en) 1996-01-29
SK147493A3 (en) 1994-07-06
NO304176B1 (no) 1998-11-09
DE69317537T2 (de) 1998-07-09
KR940013511A (ko) 1994-07-15
BG98327A (bg) 1994-08-30
CA2112014C (en) 2004-11-02
LV10688B (en) 1995-10-20
EP0605203A2 (de) 1994-07-06
TW401300B (en) 2000-08-11
FI935851L (fi) 1994-06-26

Similar Documents

Publication Publication Date Title
RU2130774C1 (ru) Фармацевтическая композиция для местного применения для лечения аллергических заболеваний глаз и носа
KR100889170B1 (ko) 안구 건조의 치료에 있어서 리멕솔론의 용도
EP0306984B1 (de) Schutzmittel für Augenzubereitungen
ES2399045T3 (es) Combinación de brimonidina y timolol para uso oftálmico tópico
JP2769253B2 (ja) 水性液剤
JPS6038323A (ja) 眼科用消炎剤
TW202114697A (zh) 用於穩定包括藥物的水性組成物之pH值的方法
CN103209683B (zh) 角鲨胺的眼用制剂
US20020161015A1 (en) Ophthalmic composition
KR102266014B1 (ko) 안질환 예방 또는 치료용 점안 조성물
JPWO2018147409A1 (ja) 水性点眼点鼻用組成物
CN103976943B (zh) 用于治疗或预防眼部疼痛的酮咯酸氨丁三醇组合物
JP2787131B2 (ja) 水性懸濁液剤
JPH085779B2 (ja) フレロキサシン点眼液
CN116847826A (zh) 包含左氧氟沙星和酮咯酸的眼用组合物、其制备方法和用途
JPH10500130A (ja) テラゾシンを含有する緑内障治療用医薬組成物
JPH02262518A (ja) 眼圧調整剤
JPH10203979A (ja) チアプロフェン酸を含有する抗眼炎症剤
JP2005053825A (ja) 点眼点鼻用組成物
JPH09295935A (ja) 抗眼炎症剤